Gnosco Revenue and Competitors
Estimated Revenue & Valuation
- Gnosco's estimated annual revenue is currently $4.7M per year.
- Gnosco's estimated revenue per employee is $189,000
Employee Data
- Gnosco has 25 Employees.
- Gnosco grew their employee count by 9% last year.
Gnosco's People
Name | Title | Email/Phone |
---|
Gnosco Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $54.4M | 183 | 6% | N/A | N/A |
#2 | $18M | 74 | -4% | N/A | N/A |
#3 | $162.7M | 482 | 39% | N/A | N/A |
#4 | $42.8M | 144 | 8% | N/A | N/A |
#5 | $26.5M | 98 | 4% | N/A | N/A |
#6 | $33.2M | 123 | -2% | N/A | N/A |
#7 | $29.7M | 110 | 12% | N/A | N/A |
#8 | $15.5M | 66 | -21% | $29.7M | N/A |
#9 | $1645.8M | 4354 | 13% | N/A | N/A |
#10 | $43.7M | 147 | 18% | N/A | N/A |
What Is Gnosco?
Gnosco offer the digital platform Dermicus, that is an easy, flexible and secure decision support platform for skin cancer and wounds. The system utilizes the camera on the doctor's mobile phone together with an application and a server platform. Clinical data and images are rapidly and easily collected by using the phone and sent to specialists for assessment, diagnosis and advice for treatment. Dermicus provides a faster and more efficient medical process and shorter time to diagnose and correct treatment. Specialist competence is digitally transferred to primary care and there is a continuous educational effect for the users. Total costs are decreased due to fewer excisions and less physical referrals to specialists, but most important diagnoses are set much faster than before. Our mission is to prevent unnecessary death, set correct diagnosis and do it more efficiently than today.
keywords:N/AN/A
Total Funding
25
Number of Employees
$4.7M
Revenue (est)
9%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $2.6M | 26 | 53% | N/A |
#2 | N/A | 27 | 200% | N/A |
#3 | $2.6M | 27 | 8% | N/A |
#4 | N/A | 28 | 75% | N/A |
#5 | $7M | 28 | 4% | N/A |